These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31307197)

  • 1. Circular RNA circHIPK3 serves as a prognostic marker to promote chronic myeloid leukemia progression.
    Feng XQ; Nie SM; Huang JX; Li TL; Zhou JJ; Wang W; Zhuang LK; Meng FJ
    Neoplasma; 2020 Jan; 67(1):171-177. PubMed ID: 31307197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hsa_circ_0006010 and hsa_circ_0002903 in peripheral blood serve as novel diagnostic, surveillance and prognostic biomarkers for disease progression in chronic myeloid leukemia.
    Zhao J; Wang G; Yan G; Zheng M; Li H; Bai Y; Zheng X; Chen Z
    BMC Cancer; 2024 Sep; 24(1):1172. PubMed ID: 39304860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simple and reliably sensitive diagnosis and monitoring of Philadelphia chromosome-positive cells in chronic myeloid leukemia by interphase fluorescence in situ hybridization of peripheral blood cells.
    Yanagi M; Shinjo K; Takeshita A; Tobita T; Yano K; Kobayashi M; Terasaki H; Naoe T; Ohnishi K; Ohno R
    Leukemia; 1999 Apr; 13(4):542-52. PubMed ID: 10214860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of microRNAs in the development, progression and drug resistance of chronic myeloid leukemia and their potential clinical significance.
    Navabi A; Akbari B; Abdalsamadi M; Naseri S
    Life Sci; 2022 May; 296():120437. PubMed ID: 35231484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypomethylation-mediated H19 overexpression increases the risk of disease evolution through the association with BCR-ABL transcript in chronic myeloid leukemia.
    Zhou JD; Lin J; Zhang TJ; Ma JC; Li XX; Wen XM; Guo H; Xu ZJ; Deng ZQ; Zhang W; Qian J
    J Cell Physiol; 2018 Mar; 233(3):2444-2450. PubMed ID: 28776669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression pattern and prognostic implication of SALL4 gene in myeloid leukemias: a case-control study.
    Farawela HM; Zawam HM; Al-Wakeel HA; El-Nagdy MH; El-Refaey FA; Abdel-Rahman HA
    Scand J Clin Lab Invest; 2019; 79(1-2):65-70. PubMed ID: 30638095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular detection of survivin expression, antiapoptotic gene, and other prognostic markers, how they are correlated and how it could be of prognostic value in chronic myeloid leukemia patient.
    Zhara M; Mourad H; Farouk G; Elbatch M; Ezzat S; Sami W
    Egypt J Immunol; 2007; 14(2):51-62. PubMed ID: 20306657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression differences of genes in the PI3K/AKT, WNT/b-catenin, SHH, NOTCH and MAPK signaling pathways in CD34+ hematopoietic cells obtained from chronic phase patients with chronic myeloid leukemia and from healthy controls.
    de Cássia Viu Carrara R; Fontes AM; Abraham KJ; Orellana MD; Haddad SK; Palma PVB; Panepucci RA; Zago MA; Covas DT
    Clin Transl Oncol; 2018 Apr; 20(4):542-549. PubMed ID: 28905209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive circular RNA expression profiles and the tumor-suppressive function of circHIPK3 in ovarian cancer.
    Teng F; Xu J; Zhang M; Liu S; Gu Y; Zhang M; Wang X; Ni J; Qian B; Shen R; Jia X
    Int J Biochem Cell Biol; 2019 Jul; 112():8-17. PubMed ID: 31026505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CR-LAAO antileukemic effect against Bcr-Abl(+) cells is mediated by apoptosis and hydrogen peroxide.
    Burin SM; Ghisla S; Ouchida AT; Aissa AF; Coelho MG; Costa TR; Marsola AP; Pinto-Simões B; Antunes LM; Curti C; Sampaio SV; de Castro FA
    Int J Biol Macromol; 2016 May; 86():309-20. PubMed ID: 26812110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression pattern of key microRNAs in patients with newly diagnosed chronic myeloid leukemia in chronic phase.
    Fallah P; Amirizadeh N; Poopak B; Toogeh G; Arefian E; Kohram F; Hosseini Rad SM; Kohram M; Teimori Naghadeh H; Soleimani M
    Int J Lab Hematol; 2015 Aug; 37(4):560-8. PubMed ID: 25833191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of p210 BCR-ABL transcript variants with clinical, parameters and disease outcome in 45 chronic myeloid leukemia patients.
    Al-Achkar W; Moassass F; Youssef N; Wafa A
    J BUON; 2016; 21(2):444-9. PubMed ID: 27273956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia.
    Zeng X; Zhao H; Li Y; Fan J; Sun Y; Wang S; Wang Z; Song P; Ju D
    Autophagy; 2015; 11(2):355-72. PubMed ID: 25701353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression profiles and functional analysis of plasma miRNAs associated with chronic myeloid leukemia phases.
    Zhang J; Jiang Y; Han X; Roy M; Liu W; Zhao X; Liu J
    Future Oncol; 2019 Mar; 15(7):763-776. PubMed ID: 30501399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA-21 Expression as Prognostic and Therapeutic Response Marker in Chronic Myeloid Leukaemia Patients.
    Mirza MAB; Guru SA; Abdullah SM; Rizvi A; Saxena A
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2379-2383. PubMed ID: 31450909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Hippo signaling pathway and Aurora kinase genes in chronic myeloid leukemia.
    Marsola APZC; Simões BP; Palma LC; Berzoti-Coelho MG; Burin SM; de Castro FA
    Med Oncol; 2018 Jan; 35(3):26. PubMed ID: 29387948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA Damage and DNA Damage Response in Chronic Myeloid Leukemia.
    Popp HD; Kohl V; Naumann N; Flach J; Brendel S; Kleiner H; Weiss C; Seifarth W; Saussele S; Hofmann WK; Fabarius A
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32053969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells.
    Ohmine K; Ota J; Ueda M; Ueno S; Yoshida K; Yamashita Y; Kirito K; Imagawa S; Nakamura Y; Saito K; Akutsu M; Mitani K; Kano Y; Komatsu N; Ozawa K; Mano H
    Oncogene; 2001 Dec; 20(57):8249-57. PubMed ID: 11781839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Droplet digital PCR for BCR/ABL(P210) detection of chronic myeloid leukemia: A high sensitive method of the minimal residual disease and disease progression.
    Wang WJ; Zheng CF; Liu Z; Tan YH; Chen XH; Zhao BL; Li GX; Xu ZF; Ren FG; Zhang YF; Chang JM; Wang HW
    Eur J Haematol; 2018 Sep; 101(3):291-296. PubMed ID: 29691899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression analysis of noncoding PCA3 gene in patients with chronic myeloid leukemia.
    Sajjadi E; Atashi A; Tajrishi MAMH; Saei Z
    J Cancer Res Ther; 2018; 14(5):1079-1082. PubMed ID: 30197352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.